CGB-600

· CAGE Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CGB-600, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo [Phase 1]